| #400 |
George Hwang |
Finsix |
1 |
| #400 |
Holger Hennig |
Bsh Hausgeräte Gmbh |
1 |
| #400 |
Birgit Hausmann |
Element Six Limited |
1 |
| #400 |
Mark Maalouf |
Gecko Health Innovations |
1 |
| #400 |
Zebadiah M. Kimmel |
Atlas5D |
1 |
| #400 |
Gangadhar Jogikalmath |
Nanopaper |
1 |
| #400 |
Steven Mark Wenglowsky |
Blueprint Medicines |
1 |
| #400 |
Theodore Alexander Betley |
Harvard University |
1 |
| #400 |
Christopher F. Claiborne |
Millennium Pharmaceuticals |
1 |
| #400 |
Piotr Indyk |
AT&T |
1 |
| #400 |
Ross L. Stein |
Millennium Pharmaceuticals |
1 |
| #400 |
Irene M. Brockman |
Whirlpool |
1 |
| #400 |
Dana Weinstein |
MIT |
1 |
| #400 |
Michael Stern |
MIT |
1 |
| #400 |
Ismail Emre Ozkumur |
The General Hospital |
1 |
| #400 |
Justin McCue |
Millipore |
1 |
| #400 |
Charles A. DiMarzio |
Northwestern University |
1 |
| #400 |
Steven A. Castleberry |
MIT |
1 |
| #400 |
Dan Feldman |
MIT |
1 |
| #400 |
Natasha Y. Frank |
Brigham and Women's Hospital |
1 |
| #400 |
Vladimir Leonid Bychkovsky |
Adobe |
1 |
| #400 |
Priyank Vijaya Kumar |
MIT |
1 |
| #400 |
Yun Liu |
MIT |
1 |
| #400 |
Michael Brandon Kremer |
RTX (Raytheon) |
1 |
| #400 |
Linbo Liu |
The General Hospital |
1 |
| #400 |
Hemant Bokil |
Boston Scientific |
1 |
| #400 |
Richard Loring Miller |
Reckitt Benckiser |
1 |
| #400 |
Jessica Artilles |
— |
1 |
| #400 |
Mark Fickett |
Google |
1 |
| #400 |
Maria Empar Rollano Hijarrubia |
Witricity |
1 |
| #400 |
Rizwan S. Dhanidina |
Akamai Technologies |
1 |
| #400 |
Soheil Feizi-Khankandi |
MIT |
1 |
| #400 |
Frederic Preffer |
The General Hospital |
1 |
| #400 |
Tanzina Labonte |
Novartis Ag |
1 |
| #400 |
Mira Wilczek |
Analog Devices |
1 |
| #400 |
Jay J. Fucetola |
MIT |
1 |
| #400 |
Jonathan Ledlie |
Nokia |
1 |
| #400 |
Adam Standley |
Advanced Silicon Group |
1 |
| #400 |
Jonathan Haar |
Eastern Wind Power |
1 |
| #400 |
Philippe de Rouffignac |
Arradiance |
1 |
| #400 |
Matt Shea |
Draper Laboratory |
1 |
| #400 |
Jon Rosenfeld |
Coleco Industries |
1 |
| #400 |
Tze Guan Tan |
Infectious Disease Research Institute |
1 |
| #400 |
Ioana Aron |
MIT |
1 |
| #400 |
Muhammad Masood |
Bose |
1 |
| #400 |
Zachary Byars |
Robert Bosch Gmbh |
1 |
| #400 |
David Lakatos |
Formlabs |
1 |
| #400 |
Ian Douglas Swett |
Google |
1 |
| #400 |
Matthew Everett Lawson |
MIT |
1 |
| #400 |
Oliver Tobias Brambrink |
Whitehead Institute For Biomedical Research |
1 |